Effective January 1, 2021, ESI will exclude Calquence from their formulary

 

This Weekly’s Hot Topics

Effective January 1, 2021, ESI will exclude Calquence from their formulary. MOASC News
Multi-Cancer Early Detection Test legislation. National News
Distribution of COVID-19 vaccine to your cancer patients. National News

MOASC Member In The News! MOASC Board Member, Dr. Ravi Patel, Director of Medical Oncology and Hematology at the Comprehensive Blood and Cancer Center (CBCC), joined KGET News to discuss Prostate Cancer. Dr. Patel shared that early screenings are important for catching the cancer diagnosis early. To read more, click here and go to MOASC News.

A live, online presentation outlining Governor Newsom’s 2021 budget priorities will be presented by California Finance Director Keely Martin Bosler on Tuesday, January 12, 2021 at 8:30 a.m. To read more, click here and go to California News.

CMS has released their annual updates to the Drug Spending Dashboards and the Medicare Part B Discarded Drug Units Report with data for 2019. The dashboards focus on average spending per dosage unit for prescription drugs in the Medicaid, Medicare Part B, and Medicare Part D programs, and track the change in average spending per dosage unit over time. To read more, click here and go to Medicare News/CMS News.

Rep. Raul Ruiz, M.D. (D-CA), an emergency physician by training, recently co-sponsored H.R. 8845, the Multi-Cancer Early Detection Screening Coverage Act which would ensure prompt access to FDA-approved multi-cancer screening tests and fuel innovation in cancer screening. This bipartisan legislation ensures that Medicare can cover groundbreaking multi-cancer early detection tests as soon as they receive FDA approval. To read more, click here and go to National News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

December 24, 2020



No comments have been posted yet.